The FDA's July 2026 review of seven peptides could have far-reaching implications beyond healthcare. As regulators evaluate potential changes to compounding eligibility, payment processors, banks, and merchants are watching closely. Learn how increased regulatory clarity may affect merchant account approvals, underwriting standards, banking relationships, and payment processing opportunities for businesses operating in the peptide industry.

Firearms merchant accounts face new risks in 2026 — rolling reserves, frozen funds, and stricter compliance rules. Here’s what’s driving the crackdown, the red flags to watch for, and how to protect your business before a freeze forces the issue.

Mastercard to go numberless by 2030 in Europe. Tokenized, biometric-secured payments are the future—are you ready?